Leveraging Patient-Reported Outcome Measures for Optimal Dose Selection in Early Phase Cancer Trials.

0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Bill Byrom, Paul Cordero, Anthony Everhart, Chris Garratt, Tim Meyer

Ngôn ngữ: eng

Ký hiệu phân loại:

Thông tin xuất bản: Canada : JMIR cancer , 2025

Mô tả vật lý:

Bộ sưu tập: NCBI

ID: 728690

Thêm vào giỏ Liên kết toàn văn

While patient-reported outcome measures are regularly incorporated into phase 3 clinical trials, they have been infrequently used in early phase trials. However, the patient's perspective is vital to fully understanding dose toxicity and selecting an optimal dose. This viewpoint paper reviews the rationale for and practical approach to collecting patient-reported outcome data in early phase oncology drug development and the rationale for electronic collection.

Tạo bộ sưu tập với mã QR